Digital Biobank
Verisense Health is building a Digital Biobank to provide the data to identify and validate Digital Biomarkers. The Digital Biobank is a repository of raw digital sensor data with associated patient reported outcomes and tokens to enable access to real world data, including medical records, claims data, pharmacy data, etc. on an anonymous basis. The Digital Biobank is being seeded with data collected by Verisense Health, both from internally sponsored studies and from external sponsors who are leveraging Verisense Health’s highly efficient infrastructure, the Digital Health Panel
The Digital Health Panel combines decentralized trial approaches with existing infrastructure and RWD.
Participant Management Partner
22 Locations
400k existing panel members
300+ diseases
Hundres of projects per year
Verisense Health sits at the center of this infrastructure with it’s custom built data collection and study management platform integrating data from a variety of partners:
Customers/ Sponsors of Research
Commission new research
Provide existing datasets
Real-World Data (RWD) Partners
Generate tokens
Provide pseudonymized participant RWD, as needed
3rd Party Device Integration
Verisense Health will work with any digital health technology provider that is committed to providing raw data. The use of raw data makes the Digital Biobank device agnostic in that any device using the same type of sensors (e.g., accelerometers) can utilize analysis algorithms developed with these data. In addition, Verisense Health will work with any device manufacturer to incorporate their data into the Digital Biobank.
Examples of Technologies that might be added to Study:
Motion and/or Biophysical sensors
BT Weight Sclaes
ECG Patches